Abstract

A new derivative of 3,7-diazabicyclo[3.3.1]nonane was studied in electrophysiological experiments, which showed high activity as a positive allosteric modulator of AMPA receptors of the CNS. In doses of 0.01 mg/kg this compound significantly improved the memory of experimental animals disturbed by maximal electric shock. The results indicate that this compound is a promising candidate for preclinical and clinical studies as a treatment for a number of psycho-neurological diseases.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call